Oryzon Genomics SA (ORYZF)
3.27
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Oryzon Genomics SG&A Expense (TTM) : 3.389M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.389M |
| March 31, 2026 | 2.603M |
| December 31, 2025 | 1.972M |
| September 30, 2025 | 1.326M |
| June 30, 2025 | 0.8694M |
| March 31, 2025 | 1.351M |
| December 31, 2024 | 1.092M |
| September 30, 2024 | 1.339M |
| June 30, 2024 | 1.152M |
| March 31, 2024 | 0.8722M |
| December 31, 2023 | 1.227M |
| September 30, 2023 | 1.462M |
| June 30, 2023 | 1.797M |
| March 31, 2023 | 2.290M |
| December 31, 2022 | 2.529M |
| September 30, 2022 | 3.015M |
| June 30, 2022 | 3.340M |
| Date | Value |
|---|---|
| March 31, 2022 | 2.851M |
| September 30, 2021 | 2.293M |
| June 30, 2021 | 1.469M |
| March 31, 2021 | 0.9133M |
| December 31, 2020 | 0.7822M |
| September 30, 2020 | 0.679M |
| June 30, 2020 | 0.559M |
| March 31, 2020 | 0.7529M |
| December 31, 2019 | 0.7964M |
| September 30, 2019 | 0.687M |
| June 30, 2019 | 0.745M |
| March 31, 2019 | 0.5029M |
| December 31, 2018 | 0.2947M |
| September 30, 2018 | 1.690M |
| June 30, 2018 | 1.506M |
| March 31, 2018 | 1.417M |
| March 31, 2016 | 1.396M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pharma Mar SA | 73.98M |
| Grifols SA | 1.318B |
| ACADIA Pharmaceuticals, Inc. | 620.29M |
| Alkermes Plc | 841.17M |
| Alnylam Pharmaceuticals, Inc. | 1.318B |